Skip to content

NRXS - Neuraxis, INC - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchN

Neuraxis, Inc.

NRXS · AMEX

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

N

NRXSNeuraxis, Inc.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $9.33
52-wk low: $2.21
Prev close: $5.45
Mkt cap: $80.1M
Beta: 1.48
P/S: 15.1x

Smart money

7 funds hold a position.

Real smart money

Funds holding this stock

7 holders

Combined position$3.6M

JS
Jim Simons
Q2 2026 13F
$1.2M
position
MW
Marshall Wace
Q2 2026 13F

Earnings

Reported Aug 11, 2026

Earnings came in 40.6% above what analysts expected.

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is not yet profitable.

Net margin: -144.4%
Market cap: $80M

Valuation

P/S15.07
P/B11.68

Quality

Operating margin-110.2%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: NRXS
Exchange: AMEX
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $80.12M
Beta: 1.48

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

11.7x

Profit margin

-144.4%

Op margin

-110.2%

ROE

-139.8%

$941K

position

CI

Citadel

Ken Griffin · Q2 2026 13F

$622K

position

4 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 4 holders

Coverage gaps for NRXS

No recent insider trade
No recent Congress trade
No recent market-voice mention

Earnings per share

-$0.19+40.6%

-$0.32 expected

Next report

What the street expects next

-139.8%

ROA-56.2%

Growth

Beta1.48